Reported figures and Equlion model projections for the next 5 years.
Gross Margin
-3.9 pt
Company
Sector average
Total Assets
+16.8%
Company
Sector average
Stock Price
+0%
Company
Sector average (own scale)
Detailed data
CNY|Thousands
Amounts in CNY (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for 瑞康医药 (Ruì Kāng Yī Yào)? It covers the balance sheet, income statement, cash flow and Equlion model projections.